TTOO T2 Biosystems Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: TTOO

Price (delayed)

$5.09

Market cap

$44.76M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$11.51

Enterprise value

$87.49M

T2 Biosystems, a leader in the rapid detection of sepsis-causing pathogens, is dedicated to improving patient care and reducing the cost of care by helping clinicians effectively treat patients faster ...

Highlights
The EPS has soared by 99% YoY and by 40% from the previous quarter
TTOO's net income is up by 28% year-on-year and by 9% since the previous quarter
TTOO's equity is down by 35% since the previous quarter but it is up by 24% year-on-year
T2 Biosystems's quick ratio has shrunk by 78% YoY and by 52% QoQ
The revenue has plunged by 58% YoY
Sector: Healthcare
Industry: Diagnostics & Research
Website: http://www.t2biosystems.com
Peers: ALDX ALIM CDNA GERN

Key stats

What are the main financial stats of TTOO
Market
Shares outstanding
8.79M
Market cap
$44.76M
Enterprise value
$87.49M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
3.61
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
12.19
Earnings
Revenue
$7.18M
EBIT
-$40.65M
EBITDA
-$38.59M
Free cash flow
-$46.95M
Per share
EPS
-$11.51
Free cash flow per share
-$9.22
Book value per share
-$9.33
Revenue per share
$1.41
TBVPS
$4.86
Balance sheet
Total assets
$24.76M
Total liabilities
$62.53M
Debt
$49.5M
Equity
-$37.77M
Working capital
-$40.7M
Liquidity
Debt to equity
-1.31
Current ratio
0.28
Quick ratio
0.15
Net debt/EBITDA
-1.11
Margins
EBITDA margin
-537.8%
Gross margin
-117%
Net margin
-636.1%
Operating margin
-676.9%
Efficiency
Return on assets
-130.5%
Return on equity
N/A
Return on invested capital
-328.5%
Return on capital employed
N/A
Return on sales
-566.4%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

TTOO stock price

How has the T2 Biosystems stock price performed over time
Intraday
5.38%
1 week
0.39%
1 month
-5.04%
1 year
-57.19%
YTD
-18.88%
QTD
-4.68%

Financial performance

How have T2 Biosystems's revenue and profit performed over time
Revenue
$7.18M
Gross profit
-$8.39M
Operating income
-$48.58M
Net income
-$45.65M
Gross margin
-117%
Net margin
-636.1%
TTOO's operating margin has dropped by 115% year-on-year
The net margin has plunged by 72% YoY but it has increased by 9% from the previous quarter
The revenue has plunged by 58% YoY
TTOO's net income is up by 28% year-on-year and by 9% since the previous quarter

Growth

What is T2 Biosystems's growth rate over time

Valuation

What is T2 Biosystems stock price valuation
P/E
N/A
P/B
N/A
P/S
3.61
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
12.19
The EPS has soared by 99% YoY and by 40% from the previous quarter
TTOO's equity is down by 35% since the previous quarter but it is up by 24% year-on-year
The revenue has plunged by 58% YoY
The P/S is 39% below the 5-year quarterly average of 5.9 but 3.1% above the last 4 quarters average of 3.5

Efficiency

How efficient is T2 Biosystems business performance
The ROIC has plunged by 87% from the previous quarter
The ROS has plunged by 69% YoY but it has grown by 9% from the previous quarter
The ROA has grown by 23% YoY and by 3.6% from the previous quarter

Dividends

What is TTOO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for TTOO.

Financial health

How did T2 Biosystems financials performed over time
TTOO's total assets is 60% less than its total liabilities
T2 Biosystems's quick ratio has shrunk by 78% YoY and by 52% QoQ
The current ratio has plunged by 74% YoY and by 38% from the previous quarter
TTOO's equity is down by 35% since the previous quarter but it is up by 24% year-on-year
The debt to equity has grown by 26% from the previous quarter but it has contracted by 10% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.